Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Study findings from a collaboration with Duke Health found that a model that incorporates ECG data from long-term continuous monitoring resulted in more accurate prediction of heart failure ...

Researchers made important gains in 2023 in the fight against cardiovascular disease (CVD), according to the American Heart Association's (AHA's) annual list of key scientific developments in the ...

-CTX310™ led to durable reductions of angiopoietin-like 3 protein (ANGPTL3) and triglyceride levels in non-human primates (NHPs) after a single dose- CTX320 is an investigational in vivo CRISPR/Cas9 ...

Exclusive Coverage of the American Heart Association (AHA) Scientific Sessions 2023 | Supplements and Featured Publications | Journals | The American Journal of Managed Care provides insights into the ...

Drugmaker price hikes that have occurred in tandem with ongoing drug shortages have not only created headaches for both hospitals and providers — but also jeopardized patient access to care, according ...

--Amgen today announced new data reinforcing the safety and efficacy of Repatha ® from the FOURIER Open Label Extension trial at the American Heart Association Scientific Sessions 2023 in Philadelphia ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will present new Phase 2 clinical data from the ongoing SHASTA-2 and MUIR studies of plozasiran ...